We are live on ! Find out more
HURA

TuHURA Biosciences
HURA

24 hedge funds and large institutions have $375K invested in TuHURA Biosciences in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

50% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 4

20% more funds holding

Funds holding: 20 → 24 (+4)

0% more ownership

Funds ownership: 0% → 0% (+0%)

61% less capital invested

Capital invested by funds: $972K → $375K (-$597K)

Holders
24
Holders Change
+4
Holders Change %
+20%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
6
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NCM
Nantahala Capital Management
Connecticut
+$87.6K
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$62K
3
VF
Virtu Financial
New York
+$30.1K
4
UBS Group
UBS Group
Switzerland
+$8.31K
5
HF
HRT Financial
New York
+$7.03K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$124K
2
Renaissance Technologies
Renaissance Technologies
New York
-$81.8K
3
Millennium Management
Millennium Management
New York
-$6.08K
4
TRCT
Tower Research Capital (TRC)
New York
-$639
5
TAM
Tucker Asset Management
Colorado
-$278
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$80K -$124K -387 -48%
NCM
2
Nantahala Capital Management
Connecticut
$64K +$87.6K +274 +415%
Acadian Asset Management
3
Acadian Asset Management
Massachusetts
$57K +$62K +194 +164%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$38K – – –
Renaissance Technologies
5
Renaissance Technologies
New York
$30K -$81.8K -256 -62%
S
6
swisspartners
Liechtenstein
$30K – – –
VF
7
Virtu Financial
New York
$18K +$30.1K +94 New
State Street
8
State Street
Massachusetts
$13K – – –
Northern Trust
9
Northern Trust
Illinois
$5K – – –
Osaic Holdings
10
Osaic Holdings
Arizona
$5K – – –
LPL Financial
11
LPL Financial
California
$5K +$4.48K +14 +117%
UBS Group
12
UBS Group
Switzerland
$5K +$8.31K +26 +1,300%
HF
13
HRT Financial
New York
$4K +$7.03K +22 New
TRCT
14
Tower Research Capital (TRC)
New York
$3K -$639 -2 -11%
ECM
15
Evergreen Capital Management
Washington
$3K – – –
TSS
16
Two Sigma Securities
New York
$3K +$5.43K +17 New
PFO
17
Pathstone Family Office
New Jersey
$2.08K +$1.6K +5 +83%
Millennium Management
18
Millennium Management
New York
$2K -$6.08K -19 -61%
ACA
19
Affinity Capital Advisors
California
$2K +$639 +2 +18%
Jane Street
20
Jane Street
New York
$2K +$3.2K +10 New
Mariner
21
Mariner
Kansas
$2K +$3.2K +10 New
FNB
22
Farmers National Bank
Kentucky
$1.22K – – –
MWM
23
Maltin Wealth Management
New Jersey
$1K – – –
TAM
24
Tucker Asset Management
Colorado
– -$278 -1 Closed
Morgan Stanley
25
Morgan Stanley
New York
– +$320 +1 New

HURA Hedge Fund Activity: Q3 2022 in Review

24 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q3 2022, worth a combined $375K — down 61% from $972K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new HURA positions and 2 closed out — a net gain of 4 holders — while 6 added to existing stakes and 4 trimmed.

The largest buyer was Nantahala Capital Management, adding an estimated $87.6K. The largest seller was Vanguard Group, cutting an estimated $124K.

  • 24 institutional investors held TuHURA Biosciences (HURA) as of Q3 2022, up from 20 in Q2 2022.
  • Funds reported $375K of TuHURA Biosciences stock for Q3 2022, down 61% quarter-over-quarter.
  • 6 funds opened new TuHURA Biosciences positions in Q3 2022 and 2 closed out, a net change of +4 holders.
  • The largest TuHURA Biosciences buyer in Q3 2022 was Nantahala Capital Management, an estimated $87.6K added.
  • The largest TuHURA Biosciences seller in Q3 2022 was Vanguard Group, an estimated $124K sold.

Based on aggregated 13F filings for Q3 2022.